Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

653.00p
   
  • Change Today:
    -7.00p
  • 52 Week High: 682.00
  • 52 Week Low: 232.50
  • Currency: UK Pounds
  • Shares Issued: 120.50m
  • Volume: 29,100
  • Market Cap: £786.85m
  • RiskGrade: 125
  • Beta: 1.92

OXB Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -30.6% -15.0%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 6.2 4.9
Pr/Book 13.1  
Latest F'cast
Revenue 43.8% 26.6%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

OXB Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 87.73 (6.57) (7.81)p n/a n/a n/a n/a 0.0%
31-Dec-21 142.80 19.88 22.77p 54.0 n/a n/a n/a 0.0%
31-Dec-22 139.99 (45.98) (41.29)p n/a n/a n/a n/a 0.0%
31-Dec-23 89.54 (188.53) (163.11)p n/a n/a n/a n/a 0.0%
31-Dec-24 128.80 (47.26) (41.75)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

OXB Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 163.07 (24.54) (29.31)p n/a n/a n/a n/a 0.0%
31-Dec-26 215.72 (1.94) (14.46)p n/a n/a n/a n/a 0.0%
31-Dec-27 273.29 22.71 4.32p 152.8 n/a n/a n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

OXB Company Announcements

Holding(s) in Company 03-Nov-2025 16:55 RNS
Total Voting Rights 03-Nov-2025 07:00 RNS
Director/PDMR Shareholding 20-Oct-2025 17:54 RNS

OXB ShareCast News

Oxford Biomedica acquires US viral vector facility 07-Oct-2025 ShareCast
Oxford Biomedica reiterates outlook as interim l... 23-Sep-2025 ShareCast
RBC Capital Markets raises target price on OXB 26-Aug-2025 ShareCast

OXB Top Newspaper Links

Need to know: Opec cuts forecast ... Tesco cuts ... 16-Aug-2008 Times
Need to know 10-May-2008 Times
DSG International may be losing its spark 12-Feb-2008 Telegraph

Latest OXB Director Deals

Traded Action Notifier PriceAmountValue
20-Oct-25 Buy Heather Preston 593.24p 6,175 £36,632.57
18-Aug-25 Sell Dame Kay Davies 500.40p 4,563 £22,833.25
15-Aug-25 Buy Roch Doliveux 449.75p 67,000 £301,332.50

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

OXB Market Data

Currency UK Pounds
Share Price 653.00p
Change Today -7.00p
% Change -1.06 %
52 Week High 682.00
52 Week Low 232.50
Volume 29,100
Shares Issued 120.50m
Market Cap £786.85m
Beta 1.92
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average
17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average
Price Trend
84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average
86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average
Income Not Available
Growth
5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average
24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 06-Nov-2025

Time Volume / Share Price
09:49 5 @ 650.01p
09:42 3 @ 653.00p
09:42 53 @ 653.00p
09:41 7 @ 653.56p
09:29 4,455 @ 655.70p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page